Citations

Clear

69 citation(s) found for "Cook, James R".

Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis
Al‐Mansour, Zeina , Li, Hongli , Cook, James R. , Couban, Stephen, Stewart, Douglas A. , Shea, Thomas C., Smith, Sonali M. , Marcellus, Deborah, Barton, Kevin, Mills, Glenn, Forman, Stephen J. , Leonard, John P. , Fisher, Richard I., Friedberg, Jonathan W. , Stiff, Patrick J. , Constine, Louis S , Porcu, Pierluigi , Winter, Jane N. , Kahl, Brad S. , LeBlanc, Michael , Rimsza, Lisa M.

Mayo Clinic

Leukemia & Lymphoma | January 10, 2019 | Volume: 60 | Issue: 8 | Pages: 1934-1941

10.1080/10428194.2018.1563691 | PMID 30628511 Get It

Microlobectomy: A Novel Form of Endoscopic Lobectomy
Dunning, Joel , Elsaegh, Mohamed, Gillaspie, Erin A. , Hansen, Henrik Jessen, Helsel, Bryan S., Naase, Hatam, Kornaszewska, Malgorzata, Will, Malcolm , Wigle, Dennis A. , Nardini, Marco , Petersen, René Horsleben , Walker, W. S. G. , Blackmon, Shanda

Mayo Clinic

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery | January 3, 2019 | Volume: 12 | Issue: 4 | Pages: 247-253

10.1177/155698451701200403 Get It

Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens
Mottok, Anja , Wright, George W. , Rosenwald, Andreas , Ott, German , Ramsower, Colleen , Braziel, Rita M., Delabie, Jan , Weisenburger, Dennis D. , Song, Joo Y. , Chan, Wing C. , Cook, James R. , Fu, Kai , Greiner, Tim O., Smeland, Erlend B., Glinsmann‐Gibson, Betty, Gascoyne, Randy D. , Staudt, Louis M. , Glinsmann-Gibson, Betty J, Steidl, Christian , Delabie, Jan , Song, Joo Y , Ramsower, Colleen A , Campo, Elı́as , Greiner, Tim, Holte, Harald , Savage, Kerry J. , Jaffe, Elaine S. , Connors, Joseph M. , Scott, David W. , Steidl, Christian , Rimsza, Lisa M. , Wright, George

Mayo Clinic

Blood | September 26, 2018 | Volume: 132 | Issue: 22 | Pages: 2401-2405

10.1182/blood-2018-05-851154 | PMID 30257882 Get It

Abstract Primary mediastinal large B-cell lymphoma (PMBCL) is recognized as a distinct entity in the World Health Organization classification. Currently, the diagnosis relies on consensus of histopathology, clinical variables, and presentation, giving rise to diagnostic inaccuracy in routine practice. Previous studies have demonstrated that PMBCL can be distinguished from subtypes of diffuse large B-cell lymphoma (DLBCL) based on gene expression signatures. However, requirement of fresh-frozen biopsy material has precluded the transfer of gene expression–based assays to the clinic. Here, we developed a robust and accurate molecular classification assay (Lymph3Cx) for the distinction of PMBCL from DLBCL subtypes based on gene expression measurements in formalin-fixed, paraffin-embedded tissue. A probabilistic model accounting for classification error, comprising 58 gene features, was trained on 68 cases of PMBCL and DLBCL. Performance of the model was subsequently evaluated in an independent validation cohort of 158 cases and showed high agreement of the Lymph3Cx molecular classification with the clinicopathological diagnosis of an expert panel (frank misclassification rate, 3.8%). Furthermore, we demonstrate reproducibility of the assay with 100% concordance of subtype assignments at 2 independent laboratories. Future studies will determine Lymph3Cx’s utility for routine diagnostic purposes and therapeutic decision making.
Microlobectomy: A Novel Form of Endoscopic Lobectomy
Dunning, Joel , Elsaegh, Mohamed, Nardini, Marco , Gillaspie, Erin A. , Petersen, René Horsleben , Hansen, Henrik Jessen, Helsel, Bryan S., Naase, Hatam, Kornaszewska, Malgorzata, Will, Malcolm , Wigle, Dennis A. , Walker, W. S. G. , Blackmon, Shanda

Mayo Clinic

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery | August 1, 2017 | Volume: 12 | Issue: 4 | Pages: 247-253

10.1097/imi.0000000000000394 | PMID 28763351 Get It

Objective Microlobectomy is a novel form of videoscopic-assisted thoracic surgery lobectomy. Strict inclusion criteria consist of the following: no intercostal incisions greater than 5 mm, 12 mm subxiphoid port, subxiphoid removal of the specimen, total endoscopic technique with CO 2 insufflation, vision through a 5-mm camera, stapling via the subxiphoid port, or with 5-mm stapling devices. Methods The combined early experiences of six hospitals from three countries were combined from September 2014 to May 2016. During that time, the study represents a consecutive cohort study of this technique. Results Seventy-two patients underwent microlobectomy. The median (range) age was 66 (27–82). Half of the patients were female. There were 48 right-sided resections and 24 on the left. There were four segmental resections and there was one right pneumonectomy. Four operations were performed robotically (with 8-mm intercostal incisions). The median (range) operative time was 180 (94–285) minutes and the blood loss was 118 (5–800) mL. There were three conversions to thoracotomy and two conversions to videoscopic-assisted thoracic surgery by means of an intercostal utility incision to complete the operation. The median (range)length of stay was 3(1–44) days and 30 patients (42%) when home by day 2 and 16 patients (22%) were discharged on day 1. There were no deaths. Five patients (7%) had a prolonged airleak. There were no wound infections and there was one incisional hernia. Conclusions We believe that microlobectomy is an interesting novel form of videoscopic-assisted thoracic surgery lobectomy and has several theoretical advantages. We have presented our early results and hope that this will stimulate others to investigate this type of videoscopic-assisted thoracic surgery lobectomy further.
THE 23‐GENE GENE EXPRESSION‐BASED ASSAY DOES NOT PREDICT INTERIM PET SCAN RESULTS AFTER ABVD IN ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA IN THE US INTERGROUP S0816 TRIAL
Li, H., Harvey, Yasmin , Chan, Fong Chun , Boyle, M., Straus, David J. , Sweetenham, John , Fanale, Michelle A. , Cook, James R. , Leonard, John P. , Friedberg, Jonathan W. , Gascoyne, Randy D. , Scott, David W. , Mottok, Anja , Evens, Andrew M. , Schöder, Heiko , Bartlett, Nancy L. , Barr, Paul M. , Hsi, Eric D. , Kahl, Brad S. , LeBlanc, Michael , Steidl, Christian , Rimsza, Lisa M. , Press, Oliver W.

Mayo Clinic

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 92-93

10.1002/hon.2437_81 Get It

MOLECULAR CLASSIFICATION OF PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA USING FORMALIN‐FIXED, PARAFFIN‐EMBEDDED TISSUE SPECIMENS – AN LLMPP PROJECT
Rosenwald, Andreas , Ott, German , Ramsower, Colleen , Braziel, Rita M., Weisenburger, Dennis D. , Chan, John, Cook, James R. , Fu, Kai , Greiner, Timothy C. , Smeland, Erlend B., Glinsmann‐Gibson, Betty, Gascoyne, Randy D. , Staudt, Louis M. , Mottok, Anja , Wright, George W. , Campo, Elı́as , Delabie, Jan , Song, Joo Y. , Chan, J.W., Holte, Harald , Jaffe, Elaine S. , Connors, Joseph M. , Scott, David W. , Steidl, Christian , Rimsza, Lisa M.

Mayo Clinic

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 59-60

10.1002/hon.2437_46 Get It

Does Anterior Cruciate Ligament Innervation Matter for Joint Function and Development of Osteoarthritis?
Nagelli, Christopher V. , Kuroki, Kei , Bozynski, Chantelle C. , Ma, Richard , Hewett, Timothy E. , Cook, James L.

Mayo Clinic

The Journal of Knee Surgery | September 20, 2016 | Volume: 30 | Issue: 04 | Pages: 364-371

10.1055/s-0036-1592145 | PMID 27648746 Get It

Sorting nexin 9 differentiates ligand-activated Smad3 from Smad2 for nuclear import and transforming growth factor β signaling
Wilkes, Mark C. , Repellin, Claire E. , Kang, Jeong Han , Andrianifahanana, Mahefatiana, Yin, Xueqian , Leof, Edward B.

Mayo Clinic

Molecular Biology of the Cell | September 3, 2015 | Volume: 26 | Issue: 21 | Pages: 3879-3891

10.1091/mbc.e15-07-0545 | PMID 26337383 Get It

Transforming growth factor β (TGFβ) is a pleiotropic protein secreted from essentially all cell types and primary tissues. While TGFβ’s actions reflect the activity of a number of signaling networks, the primary mediator of TGFβ responses are the Smad proteins. Following receptor activation, these cytoplasmic proteins form hetero-oligomeric complexes that translocate to the nucleus and affect gene transcription. Here, through biological, biochemical, and immunofluorescence approaches, sorting nexin 9 (SNX9) is identified as being required for Smad3-dependent responses. SNX9 interacts with phosphorylated (p) Smad3 independent of Smad2 or Smad4 and promotes more rapid nuclear delivery than that observed independent of ligand. Although SNX9 does not bind nucleoporins Nup153 or Nup214 or some β importins (Imp7 or Impβ), it mediates the association of pSmad3 with Imp8 and the nuclear membrane. This facilitates nuclear translocation of pSmad3 but not SNX9.
Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases
Andrianifahanana, Mahefatiana, Wilkes, Mark C. , Rahimi, Rod A. , Repellin, Claire E. , Edens, Maryanne, Wittenberger, Joshua, Yin, Xueqian , Maidl, Elizabeth, Becker, Jackson, Leof, Edward B. , Gupta, Shiv K.

Mayo Clinic

The FASEB Journal | August 3, 2013 | Volume: 27 | Issue: 11 | Pages: 4444-4454

10.1096/fj.12-224907 | PMID 23913859 Get It

Transforming growth factor β (TGFβ) has significant profibrotic activity both in vitro and in vivo . This reflects its capacity to stimulate fibrogenic mediators and induce the expression of other profibrotic cytokines such as platelet‐derived growth factor (PDGF) and epidermal growth factor (EGF/ErbB) ligands. Here we address both the mechanisms by which TGFβ induced ErbB ligands and the physiological significance of inhibiting multiple TGFβ‐regulated processes. The data document that ErbB ligand induction requires PDGF receptor (PDGFR) mediation and engages a positive autocrine/paracrine feedback loop via ErbB receptors. Whereas PDGFRs are essential for TGFβ‐stimulated ErbB ligand up‐regulation, TGFβ‐specific signals are also required for ErbB receptor activation. Subsequent profibrotic responses are shown to involve the cooperative action of PDGF and ErbB signaling. Moreover, using a murine treatment model of bleomycin‐induced pulmonary fibrosis we found that inhibition of TGFβ/PDGF and ErbB pathways with imatinib plus lapatinib, respectively, not only prevented myofibroblast gene expression to a greater extent than either drug alone, but also essentially stabilized gas exchange (oxygen saturation) as an overall measure of lung function. These observations provide important mechanistic insights into profibrotic TGFβ signaling and indicate that targeting multiple cytokines represents a possible strategy to ameliorate organ fibrosis dependent on TGFβ.—Andrianifahanana, M., Wilkes, M. C., Gupta, S. K., Rahimi, R. R., Repellin, C. E., Edens, M., Wittenberger, J., Yin, X., Maidl, E., Becker, J., Leof, E. B. Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases. FASEB J . 27, 4444‐4454 (2013). www.fasebj.org
Retromer maintains basolateral distribution of the type II TGF-β receptor via the recycling endosome
Yin, Xueqian , Wilkes, Mark C. , Leof, Edward B. , Murphy, Stephen J. , Ji, Yan

Mayo Clinic

Molecular Biology of the Cell | May 30, 2013 | Volume: 24 | Issue: 14 | Pages: 2285-2298

10.1091/mbc.e13-02-0093 | PMID 23720763 Get It

Transforming growth factor β (TGF-β) is critical for the development and maintenance of epithelial structures. Because receptor localization and trafficking affect the cellular and organismal response to TGF-β, the present study was designed to address how such homeostatic control is regulated. To that end, we identify a new role for the mammalian retromer complex in maintaining basolateral plasma membrane expression of the type II TGF-β receptor (TβRII). Retromer and TβRII associate in the presence or absence of TGF-β ligand. After retromer knockdown, although TβRII internalization and trafficking to a Rab5-positive compartment occur as in wild-type cells, receptor recycling is inhibited. This results in TβRII mislocalization from the basolateral to both the basolateral and apical plasma membranes independent of Golgi transit and the Rab11-positive apical recycling endosome. The data support a model in which, after initial basolateral TβRII delivery, steady-state polarized TβRII expression is maintained by retromer/TβRII binding and delivery to the common recycling endosome.